OpenSAFELY Codelists

([X]Deoxybarbiturates causing adverse effects in therapeutic use) or ([X]Adverse reaction to named anaesthetic agents) U6063 (Extinct)

[X] Adverse reaction peripheral nerve/plexus-blocking anaesthetic
[X] Adverse reaction to bupivacaine hydrochloride
[X] Adverse reaction to cocaine
[X] Adverse reaction to lignocaine hydrochloride
[X] Adverse reaction to local anaesthetics NOS
[X] Adverse reaction to other local anaesthetics
[X] Adverse reaction to prilocaine hydrochloride
[X] Adverse reaction to procaine hydrochloride
[X] Adverse reaction to spinal anaesthetic
[X] Adverse reaction to surface and infiltration anaesthetic
[X] Adverse reaction to tetracaine
[X]Deoxybarbiturates causing adverse effects in therapeutic use

[X]Adverse reaction drug primarily affecting nervous system: [autonomic] or [CNS] U60B. (Extinct)

[X] Adverse reaction to autonomic nervous system drugs
[X]Drugs primarily affecting the central nervous system causing adverse effects in therapeutic use

[X]Agents primarily acting on smooth and skeletal muscles and the respiratory system causing adverse effects in therapeutic use U60F. (Current)
[X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use U604. (Current)
[X]Agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use U60C. (Current)
[X]Agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use U60D. (Current)
[X]Agents primarily affecting water-balance and mineral and uric acid metabolism causing adverse effects in therapeutic use U60E. (Current)
[X]Anaesthetics and therapeutic gases causing adverse effects in therapeutic use U608. (Current)
[X]Analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use U605. (Current)
[X]Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use U606. (Current)
[X]Bacterial vaccines causing adverse effects in therapeutic use U60J. (Current)
[X]Central nervous system stimulants causing adverse effects in therapeutic use, not elsewhere classified U60A. (Current)
[X]Drugs primarily affecting the central nervous system causing adverse effects in therapeutic use XE22r (Current)
[X]Hormones and their synthetic substitutes and antagonists causing adverse effects in therapeutic use, not elsewhere classified U602. (Current)
[X]Other and unspecified drugs and medicaments causing adverse effects in therapeutic use U60H. (Current)
[X]Other and unspecified vaccines and biological substances causing adverse effects in therapeutic use U60K. (Current)
[X]Other systemic anti-infectives and antiparasitics causing adverse effects in therapeutic use U601. (Current)
[X]Primarily systemic agents causing adverse effects in therapeutic use U603. (Current)
[X]Psychotropic drugs causing adverse effects in therapeutic use, not elsewhere classified U609. (Current)
[X]Sedatives, hypnotics and antianxiety drugs causing adverse effects in therapeutic use U607. (Current)
[X]Systemic antibiotics causing adverse effects in therapeutic use U600. (Current)
[X]Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs causing adverse effects in therapeutic use U60G. (Current)

CTV3 Concept: `U60..`

[X]Drugs, medicaments and biological substances causing adverse effects in therapeutic use `U60..` (Current)

CTV3 Concept: U60..

[X]Drugs, medicaments and biological substances causing adverse effects in therapeutic use U60.. (Current)

CTV3 Concept: `U60..`

[X]Drugs, medicaments and biological substances causing adverse effects in therapeutic use `U60..` (Current)